Sentence examples for mutant of type from inspiring English sources

Here, it is observed that the deletion mutant of type III secretion system in E. coli strain EC10 exhibited defects in the invasion and intracellular survival in Acanthamoeba castellanii (a keratitis isolate) compared to its parent strain.

The dl520 virus is a deletion mutant of type 5 human adenovirus expressing 12S, but not 13S, E1A [9].

For instance, we write c ^ A B for the amount of care provided by a mutant of type A whose partner is of type B. First, the mortality risk of a mutant of type A after mating with a typical individual of type B is (21) m ^ A B = m A (c ^ A B ).

Dominant-negative mutant of type II TGFβ receptor pCMV5 HA-TβRII ∆Cyt) tHA-TβRII ∆Cyterminal kinase domain and is unable thatctivate TβRI [ 20] was obtained from Addgene (placksd 14051).

The average mortality risk between reproductive bouts for good and poor mutants is then, respectively, (22) m ^ G = g 2 m ^ G G + (1 − g 2 ) m ^ G P, and (23) m ^ P = g 2 m ^ P G + (1 − g 2 ) m ^ P P. Next, the expected brood productivity from a mating between a mutant of type A and a typical individual of type B is (24) b ^ A B = b (c ^ A B + c B A ).

Regardless, further work is still needed to characterize the protective response(s) elicited by vaccination with attenuated mutants of type A or type B F. tularensis, and define the antigenic determinants responsible for stimulating this response.

For the mutants of type Ia TR, this ratio is between (5 12) that of TR1 and that of the type Ib and type II TRs.

Cross-comparison of mutant phenotypes revealed that all mutants of type I and type II also showed altered capacity to remobilize oil when switching to the oil remobilization condition.

Both groups cited, using mutants of type I IP3Rs, declared that IP3R phosphorylation by Akt promotes survival, but only the work of Roderick's group connected it to an inhibition of ER Ca2+ release.

Structural data mining performed by the fitness function in Genetic Algorithm gave pattern identities between HIV-1 protease (wild type and mutants) of sub type B against organic leads and FDA approved inhibitors of HIV-1 protease.

We then generated a M44L mutant of wild-type procaspase-3 to further evaluate the role of Met-44 in caspase-3 activity regulation.